BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21153385)

  • 1. Dual-radionuclide brain SPECT for the differential diagnosis of parkinsonism.
    El Fakhri G; Ouyang J
    Methods Mol Biol; 2011; 680():237-46. PubMed ID: 21153385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
    Vaamonde J; Ibáñez R; García AM; Poblete V
    Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
    Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
    J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1.
    Hu P; Chen L; Zhang HQ; Li JR; Liang H
    Chin Med J (Engl); 2004 Jul; 117(7):1056-9. PubMed ID: 15265382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of magnetic resonance imaging (MRI) and single photon emission computing tomography (SPECT) for the differential diagnosis of Parkinson's disease and other neurodegenerative disorders presenting as parkinsonism].
    Kohira I
    Nihon Rinsho; 1997 Jan; 55(1):39-42. PubMed ID: 9014421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders.
    Chun K; Kong E; Cho I
    Medicine (Baltimore); 2021 Aug; 100(34):e27019. PubMed ID: 34449475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical parkinsonism].
    Tysnes OB; Vilming ST
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2077-80. PubMed ID: 18846125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter binding in chronic manganese intoxication.
    Huang CC; Weng YH; Lu CS; Chu NS; Yen TC
    J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Yen TC; Tsai CH; Chen RS; Chang HC
    Mov Disord; 2002 Sep; 17(5):1046-51. PubMed ID: 12360557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal evaluation using FP-CIT in patients with parkinsonism.
    Martínez-Valle Torres MD; Ortega Lozano SJ; Gómez Heredia MJ; Amrani Raissouni T; Ramos Moreno E; Moya Espinosa P; Jiménez-Hoyuela JM
    Neurologia; 2014; 29(6):327-33. PubMed ID: 24139386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha caused reversible parkinsonism.
    Lu CS; Kao WY; Lin JC; Chang PY
    Clin Neuropharmacol; 2015; 38(3):119-20. PubMed ID: 25970283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of imaging in the diagnosis of vascular parkinsonism.
    Zijlmans JC
    Neuroimaging Clin N Am; 2010 Feb; 20(1):69-76. PubMed ID: 19959019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
    Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
    Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings.
    Su CS; Chang WN; Huang SH; Lui CC; Pan TL; Lu CH; Chuang YC; Huang CR; Tsai NW; Hsieh MJ; Chang CC
    Mov Disord; 2010 Mar; 25(4):452-8. PubMed ID: 20108380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up.
    Hambÿe AS; Vervaet A; Dethy S
    Nucl Med Commun; 2010 Jun; 31(6):583-9. PubMed ID: 20429096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnostics of Parkinson's disease with nuclear medicine procedures].
    Meyer PT; Amtage F; Hellwig S
    Nervenarzt; 2014 Jun; 85(6):680-9. PubMed ID: 24821290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.
    Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
    AJNR Am J Neuroradiol; 2015 Feb; 36(2):236-44. PubMed ID: 24924549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.